4

PRIMARY DOCUMENT

Company: NYMOX PHARMACEUTICAL CORP
Filed: May 31, 2019
Period of Report: May 30, 2019
Accession Number: 0001651844-19-000004

View Document ↗ View on SEC.gov ↗